Marcadores moleculares derivados da bombesina para diagnóstico de tumores por spect e PET

Marcadores moleculares derivados da bombesina para diagnóstico de tumores por spect e PET

Show other versions (1)

Made available in DSpace on 2014-10-09T12:34:55Z (GMT). No. of bitstreams: 0 === Made available in DSpace on 2014-10-09T14:06:59Z (GMT). No. of bitstreams: 0 === Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) === Tese (Doutoramento) === IPEN/T === Instituto de Pesquisas Energeticas e...

Full description

Bibliographic Details
Main Author:	PUJATTI, PRISCILLA B.
Other Authors:	Orientador: Elaine Bortoleti de Araujo
Format:	Others
Published:	2012
Subjects:	TUMOR CELLS NEOPLASM PROSTATE DIAGNOSIS AMINO ACIDS BIOASSAY GALLIUM 68 MICE POSITRON COMPUTED TOMOGRAPHY SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY
Online Access:	http://repositorio.ipen.br:8080/xmlui/handle/123456789/10115

Similar Items

Marcadores moleculares derivados da bombesina para diagnóstico de tumores por spect e PET
by: PUJATTI, PRISCILLA B.
Published: (2012)

Estudo da marcação com Indio-111 e Gálio-68 de derivados da bombesina e avaliação das propriedades biológicas para aplicação em SPECT e PET
by: OLIVEIRA, RICARDO de S.
Published: (2014)

Estudo da marcação com Indio-111 e Gálio-68 de derivados da bombesina e avaliação das propriedades biológicas para aplicação em SPECT e PET
by: OLIVEIRA, RICARDO de S.
Published: (2014)

Bone: From planar imaging to SPECT & PET/CT
by: Mihailović Jasna, et al.
Published: (2012-01-01)

Application Progress of 68Ga-PSMA PET/CT in Recurrent Prostate Cancer
by: YANG Liping, et al.
Published: (2018-07-01)

Unusual presentation of bladder paraganglioma: Comparison of 131I MIBG SPECT/CT and 68Ga DOTANOC PET/CT
by: Tarun Kumar Jain, et al.
Published: (2016-01-01)

Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography compared with diagnostic computed tomography in relapsed prostate cancer
by: Marcus Edward Asokendaran, et al.
Published: (2019-01-01)

SPECT/CT for tumour imaging
by: Fettich Jure, et al.
Published: (2012-01-01)

Marcadores moleculares derivados da Bombesina para diagnóstico de tumores por SPECT e PET
by: Priscilla Brunelli Pujatti
Published: (2012)

Marcadores moleculares derivados da Bombesina para diagnóstico de tumores por SPECT e PET
by: Pujatti, Priscilla Brunelli
Published: (2012)

Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography
by: Manoj Gupta, et al.
Published: (2021-01-01)

Dynamic 11C-Choline PET / CT for the primary diagnosis of prostate cancer
by: Shay Golan, et al.

Impact of 68GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study
by: Aline B. Mattiolli, et al.

False-positive prostate cancer bone metastases on magnetic resonance imaging correctly classified on gallium-68-prostate-specific membrane antigen positron emission tomography computed tomography
by: Sofiullah Olayinka Abubakar, et al.
Published: (2018-01-01)

Comparison of 68Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis
by: Sui Wai Ling, et al.
Published: (2021-11-01)

Intense fluoro-2-deoxyglucose uptake in high-grade prostatic adenocarcinoma with negligible prostate-specific membrane antigen expression
by: Tansel Cakir, et al.
Published: (2019-01-01)

Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
by: Melissa E. Rodnick, et al.
Published: (2020-11-01)

Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings
by: Felipe de Galiza Barbosa, et al.
Published: (2020-03-01)

Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
by: Justin W. Hicks, et al.
Published: (2010-11-01)

11C-Choline PET/CT and PSA kinetics
by: Castellucci Paolo, et al.
Published: (2012-01-01)

68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography for prostate cancer imaging: A narrative literature review
by: Jose M Oliveira, et al.
Published: (2017-01-01)

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
by: Jonatan Dewulf, et al.
Published: (2020-07-01)

Potential of asphericity as a novel diagnostic parameter in the evaluation of patients with 68Ga-PSMA-HBED-CC PET-positive prostate cancer lesions
by: Sebastian Meißner, et al.
Published: (2017-10-01)

Is there the role of 18F-choline PET/CT in prostate cancer patients?
by: Hodolič Marina
Published: (2012-01-01)

SPECT-CT in breast cancer
by: Sergieva Sonia, et al.
Published: (2012-01-01)

Neuroendocrine prostate cancer or prostatitis? An unusual false positive on gallium-68 DOTA-Tyr3-octreotate positron emission tomography/computed tomography in a patient with known metastatic neuroendocrine tumor
by: Matthew Q Schmidt, et al.
Published: (2019-01-01)

A case of hepatic focal nodular hyperplasia mimicking hepatocellular carcinoma identified on gallium-68-prostate-specific membrane antigen positron emission tomography/computed tomography
by: Seckin Bilgic, et al.
Published: (2021-01-01)

Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies
by: Giulia Orteca, et al.
Published: (2019-02-01)

Is there a Role for Gallium-67 Citrate SPECT/CT, in Patients with Renal Impairment or Who are Renal Transplant Recipients, in Identifying and Localizing Suspected Infection?
by: Ewa Nowosinska, et al.
Published: (2015-01-01)

A comparative study of 68Gallium-prostate specific membrane antigen positron emission tomography-computed tomography and magnetic resonance imaging for lymph node staging in high risk prostate cancer patients: An initial experience
by: Manoj Gupta, et al.
Published: (2017-01-01)

Initial experience of Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography imaging in evaluation of biochemical recurrence in prostate cancer patients
by: Aravintho Natarajan, et al.
Published: (2019-01-01)

Dramatic polarization in genitourinary expert opinions regarding the clinical utility of positron emission tomography (PET) imaging in prostate cancer
by: Kiri A. Sandler, et al.

Gallium-68 Dota-Tate positron emission tomography/computed tomography: Scintigraphic changes of adrenal glands following management of ectopic cushing′s syndrome by steroidogenesis inhibitors
by: Yu-Ting Huang, et al.
Published: (2014-01-01)

PET/CT in renal and bladder cancers
by: Balenović Antonija, et al.
Published: (2012-01-01)

Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
by: Timothy N. Kwan, et al.
Published: (2021-06-01)

Updates of prostate cancer staging: Prostate-specific membrane antigen
by: Niranjan J Sathianathen, et al.
Published: (2016-12-01)

Influence of X-ray computed tomography (CT) exposure and reconstruction parameters on positron emission tomography (PET) quantitation
by: Ivan Ho Shon, et al.
Published: (2020-10-01)

Rare malignant insulinoma with multiple liver metastases derived from ectopic pancreas: 3-year follow-up and literature review
by: Liu Q, et al.
Published: (2018-04-01)

Pitfalls of FDG-PET in the prostate for the surgical oncologist
by: Ellen O'Connor, et al.
Published: (2020-11-01)

Extended lymphadenectomy for high-risk prostate cancer in patients with chronic lymphocytic leukemia may not be necessary: a report of two cases
by: Yinjie Zhu, et al.
Published: (2019-07-01)